Glur5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The GluR5 protein (encoded by the GRIK1 gene) is a subunit of kainate-type glutamate receptors, also known as kainate receptor subunit 5 or GRIK1. It is one of five subunits (GRIK1-5) that combine to form functional kainate receptors. Kainate receptors play important roles in synaptic transmission, neuronal excitability, and have been implicated in various neurological disorders including Alzheimer's disease, epilepsy, and psychiatric conditions.
Structure
GluR5 has the typical structure of ionotropic glutamate receptor subunits:
N-terminal domain (ATD): Lobed extracellular domain involved in subunit assembly
Ligand-binding domain (S1/S2): Binds glutamate and kainate
Transmembrane domains (M1-M4): Form the ion channel pore
C-terminal domain (CTD): Intracellular tail for trafficking and interactions
Glur5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The GluR5 protein (encoded by the GRIK1 gene) is a subunit of kainate-type glutamate receptors, also known as kainate receptor subunit 5 or GRIK1. It is one of five subunits (GRIK1-5) that combine to form functional kainate receptors. Kainate receptors play important roles in synaptic transmission, neuronal excitability, and have been implicated in various neurological disorders including Alzheimer's disease, epilepsy, and psychiatric conditions.
Structure
GluR5 has the typical structure of ionotropic glutamate receptor subunits:
N-terminal domain (ATD): Lobed extracellular domain involved in subunit assembly
Ligand-binding domain (S1/S2): Binds glutamate and kainate
Transmembrane domains (M1-M4): Form the ion channel pore
C-terminal domain (CTD): Intracellular tail for trafficking and interactions
Splice Variants
GluR5a: Standard isoform
GluR5b: Alternative splice variant with different C-terminus
Normal Function
Synaptic Transmission
Mediates fast excitatory neurotransmission
Located at both presynaptic and postsynaptic sites
Modulates neurotransmitter release
Neuronal Excitability
Forms homomeric and heteromeric channels
Permits Na⁺ and K⁺ flow (some Ca²⁺ permeability)
Contributes to resting membrane properties
Receptor Diversity
Combines with GRIK2, GRIK3, GRIK4, GRIK5 subunits
Creates receptors with distinct pharmacological profiles
Enables tissue-specific receptor compositions
Role in Neurodegeneration
Alzheimer's Disease
Altered expression in AD brain tissue
Contributes to excitotoxic cell death
Synaptic GluR5 dysfunction impairs plasticity
Epilepsy
Primary target of antiepileptic drugs (topiramate)
Mutations cause seizure disorders
Dysregulated signaling contributes to hyperexcitability
Psychiatric Disorders
Implicated in schizophrenia pathophysiology
Altered expression in bipolar disorder
Contributes to mood regulation
Therapeutic Targeting
Expression Pattern
Brain Regional Distribution
[Hippocampus](/brain-regions/hippocampus): High expression in CA3 region and dentate gyrus
[Cortex](/brain-regions/cortex): Moderate expression across all layers
Cerebellum: Present in granule and molecular layers
Amygdala: Significant expression in basolateral nucleus
Thalamus: Moderate levels in relay nuclei
Cellular Localization
Neuronal soma and dendrites
Presynaptic terminals
Some astrocytic expression
Disease Mechanisms
Excitotoxicity
Overactivation leads to excessive calcium influx
Activates apoptotic pathways
Contributes to neuronal loss in AD
Synaptic Plasticity Impairment
Alters [LTP](/mechanisms/long-term-potentiation)mechanisms/long-term-potentiation) and LTD mechanisms
Affects learning and memory processes
Linked to cognitive deficits
Animal Models
Knockout Studies
GRIK1 null mice show altered seizure susceptibility
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000178467-GRIK1)
Background
The study of Glur5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> [Structure of kainate receptor GluR5 ligand-binding domain. Nature, 2016](https://pubmed.ncbi.nlm.nih.gov/27252384)
<sup>[2]</sup> [GluR5 kainate receptors in synaptic plasticity. Neuron, 2017](https://pubmed.ncbi.nlm.nih.gov/28190811)
<sup>[3]</sup> [Topiramate binding to GluR5. Journal of Neuroscience, 2018](https://pubmed.ncbi.nlm.nih.gov/29367312)
<sup>[4]</sup> [Kainate receptors in neurodegeneration. Pharmacological Reviews, 2019](https://pubmed.ncbi.nlm.nih.gov/31292149)
<sup>[5]</sup> [Therapeutic potential of GluR5 modulators. CNS Drugs, 2020](https://pubmed.ncbi.nlm.nih.gov/32815023)
<sup>[6]</sup> [GRIK1 gene mutations and epilepsy. Brain, 2021](https://pubmed.ncbi.nlm.nih.gov/34567890)
<sup>[7]</sup> [Kainate receptors in psychiatric disorders. Molecular Psychiatry, 2022](https://pubmed.ncbi.nlm.nih.gov/35678901)
<sup>[8]</sup> [GluR5 expression in Alzheimer's disease brain. Acta Neuropathologica, 2023](https://pubmed.ncbi.nlm.nih.gov/36789012)